FDA Provides Breakthrough Device Designation to MeMed BV Flex

FRIDAY, March 20, 2026-- The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections."This is the kind of diagnostic innovation health...